Bank of America’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27,587
Closed -$65.1K 8682
2025
Q2
$65.1K Sell
27,587
-2,600
-9% -$6.37K ﹤0.01% 6706
2025
Q1
$42.3K Buy
30,187
+13,700
+83% +$22.9K ﹤0.01% 6792
2024
Q4
$29.8K Buy
16,487
+15,400
+1,417% +$20.9K ﹤0.01% 6754
2024
Q3
$1.35K Sell
1,087
-950
-47% -$1.29K ﹤0.01% 7188
2024
Q2
$2.85K Buy
2,037
+950
+87% +$1.26K ﹤0.01% 7093
2024
Q1
$1.8K Hold
1,087
﹤0.01% 7138
2023
Q4
$1.76K Sell
1,087
-101
-9% -$152 ﹤0.01% 7144
2023
Q3
$2.55K Buy
+1,188
New +$2.54K ﹤0.01% 7113

Other funds holding THTX

Bank of America's THTX Position: Q3 2025 in Review

Bank of America sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 27,587 shares — an estimated $65.1K sold.

Bank of America first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $65.1K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Bank of America reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 27,587 Theratechnologies shares in Q3 2025, an estimated $65.1K.
  • Bank of America first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Bank of America's Theratechnologies position peaked at $65.1K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.